Billiontoone Inc stock is traded at $101.59, with a volume of 41,579. It is down -3.39% in the last 24 hours and up +3.54% over the past month. BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Previous Close:
$105.15
Open:
$105.06
24h Volume:
41,579
Relative Volume:
0.05
Market Cap:
$4.85B
Revenue:
$354.54M
Net Income/Loss:
$23.65M
P/E Ratio:
219.56
EPS:
$0.4627
Net Cash Flow:
-
1W Performance:
-11.62%
1M Performance:
+3.54%
6M Performance:
+22.95%
1Y Performance:
+12.88%
1-Day Range:
$100.53$105.06
1-Week Range:
$100.53$115.44
52-Week Range:
$61.96$150.44
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
650-460-2551Address
1035 O'BRIEN DRIVE, MENLO PARK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS